NUS researchers derive optimal drug combination against COVID-19 using AI
Thursday, December 10th 2020
Using a ground-breaking artificial intelligence (AI) platform, researchers from the National University of Singapore (NUS) have derived the optimal combination of available therapies against SARS-CoV-2, the cause of COVID-19.
Known as ‘IDentif.AI’ (Optimising Infectious Disease Combination Therapy with Artificial Intelligence), the platform investigated 12 potential drug candidates, representing over 530,000 possible drug combinations. The identification of this optimal drug combination was completed within two weeks, cutting down the number of tests typically needed by hundreds of thousands.
In a press statement, NUS said the study used patient-derived, live SARS-CoV-2 to test the 12-drug set.
Singaporean Researchers Use Artificial Intelligence to Identify Optimal COVID-19 Combination Drug Treatment
techtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techtimes.com Daily Mail and Mail on Sunday newspapers.
AI platform finds best combination of available therapies against COVID-19
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.